AEterna Zentaris Inc. Stock News

Aeterna Zentaris (AEZS) receives a notice from Nasdaq, which grants an additional 180 calendar days, through Jul

CHARLESTON, S.C., Jan. 26, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commer

Aeterna Zentaris (AEZS) provided pipeline update and business outlook.Aeterna CEO Klaus Paulini said that in 2021 the company in-licensed six new pre-clinical development programs,…

– Company advancing diversified portfolio focused on areas of significant unmet medical need– Supported by solid financial position with cash to fund operations beyond 2023

– Live video webcast presentation on Wednesday, January 26th at 9:00 AM ET

– Live video webcast presentation on Wednesday, January 26 th at 9:00 AM ET

CHARLESTON, S.C., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commer

CHARLESTON, S.C., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commerci

Aeterna Zentaris Inc. (AEZS) shares closed today 10.9% higher than it did at the end of yesterday. The stock is currently up 10.9% year-to-date, down 7.4% over the past 12 months, and down 88.7% over the past five years. Today, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 0.6%. Trading Activity Shares traded as high as $0.40 and as low as $0.35 this week.Shares closed 89.1% below its 52-week high and 12.5% above its 52-week low.Trading volume this week was 34.0% higher than the 10-day average and 141.7% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.9. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed above its Bollinger band, indicating it may be overbought. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector today, lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date beats the peer average by 142.9% The company's stock price performance over the past 12 months beats the peer average by -13.1% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Aeterna Zentaris Inc. (AEZS) shares closed 2.2% lower than its previous 52 week low, giving the company a market cap of $46M. The stock is currently down 10.7% year-to-date, down 11.2% over the past 12 months, and down 89.3% over the past five years. This week, the Dow Jones Industrial Average rose 2.6%, and the S&P 500 rose 3.0%. Trading Activity Trading volume this week was 86.6% higher than the 20-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 1.7. Technical Indicators The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.MACD, a trend-following momentum indicator, indicates an upward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis Per Group Comparative Performance The company's stock price performance year-to-date lags the peer average by 6.5% The company's stock price performance over the past 12 months lags the peer average by 27.6% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Some of the stocks that may grab investor focus today are: NeuBase Therapeutics, Inc. (NASDAQ: NBSE) reported a net loss of around $25.4 million, or $0.93 per share for the fiscal year ended Septembe

Aeterna Zentaris Inc. (NASDAQ:AEZS) with the stream of -0.54% also noticed, India Inuvo, Inc. (AMEX:INUV) encountered a rapid change of 2.18% in the last hour of Thursdays trading session. Aeterna The post Foreshadowing Stock: Aeterna Zentaris Inc. (NASDAQ:AEZS), Inuvo, Inc. (AMEX:INUV) appeared first on Stocks Equity .

– Well-established finance professional with over 20 years of experience gained in pharmaceutical, biopharma and professional services sectors

Well-established finance professional with over 20 years of experience gained in pharmaceutical, biopharma and professional services sectors